E-COLI

Escherichia coli (E. coli) Overview

Diseases

  • Urinary Tract Infections (UTI):

    • E. coli is the predominant cause of both community-acquired and healthcare-associated urinary tract infections, accounting for approximately 80-85% of cases.

    • Symptoms include dysuria, urgency, frequency of urination, and suprapubic pain. In cases of pyelonephritis, flank pain and fever may also be present.

  • Sepsis:

    • E. coli is a leading cause of sepsis, particularly among hospitalized patients and those with weakened immune systems.

    • It can enter the bloodstream through urinary tract infections, intra-abdominal infections, or pneumonia, leading to systemic inflammatory response syndrome (SIRS).

  • Neonatal Meningitis:

    • E. coli is one of the major bacterial pathogens responsible for meningitis in newborns, particularly strains encapsulated with the K1 antigen.

    • Risk factors include prematurity, low birth weight, and prolonged rupture of membranes.

  • Diarrhea:

    • Traveler’s Diarrhea: Caused mainly by enterotoxigenic E. coli (ETEC), which produces heat-labile (LT) and heat-stable (ST) toxins, resulting in watery diarrhea that is typically self-limiting and brief in duration.

    • Enterohemorrhagic E. coli (EHEC): Notably the O157:H7 strain, which produces Shiga toxin, causing severe abdominal cramping, bloody diarrhea, and complications like hemolytic-uremic syndrome (HUS), which can lead to acute kidney failure. This pathogen is often linked to contaminated food and water sources.

Pathogenesis

  • Reservoirs:

    • E. coli resides in the intestines of healthy humans and animals. Certain strains, such as O157:H7, are associated with cattle, highlighting the zoonotic nature of some pathogenic strains.

  • Key Factors:

    • Pili:

      • Specialized structures that facilitate adherence to uroepithelial cells in the urinary tract, critical for the development of UTIs. P fimbriae are particularly significant in ascending infections.

    • Capsule:

      • A polysaccharide layer that helps E. coli evade phagocytosis by immune cells, enhancing its virulence during infections.

  • Toxins:

    • Heat-labile Toxin (LT):

      • Stimulates adenylate cyclase, increasing cAMP levels in enterocytes, leading to secretion of water and electrolytes, hence causing diarrhea.

    • Heat-stable Toxin (ST):

      • Activates guanylate cyclase, increasing cGMP levels, contributing to fluid secretion.

    • Shiga Toxin:

      • Produced by EHEC, it inhibits protein synthesis in host cells, contributing to bloody diarrhea and the characteristic effects of HUS, such as hemolytic anemia and acute renal failure.

Clinical Features

  • Intestinal Infections:

    • Traveler’s Diarrhea (ETEC):

      • Typically presents with watery, non-bloody diarrhea, abdominal cramps, and mild fever for a duration of 3-7 days.

    • Bloody Diarrhea (EHEC):

      • Characterized by severe abdominal pain, bloody stools, and potential for HUS, manifesting with symptoms like pallor, oliguria, and petechiae due to kidney involvement.

  • Extraintestinal Infections:

    • UTI:

      • Symptoms include dysuria, urgency, increased frequency, and possible flank pain. In cases of pyelonephritis, systemic symptoms like fever and chills may be present.

    • Neonatal Meningitis:

      • Symptoms may include fever, irritability, poor feeding, and signs of increased intracranial pressure (e.g., bulging fontanelle).

    • Sepsis:

      • Clinical manifestations typically include fever, chills, hypotension, elevated heart rate, and potential multi-organ dysfunction due to systemic spread of infection.

Diagnosis

  • Lab Features:

    • Lactose Fermentation:

      • E. coli ferments lactose, producing pink colonies on MacConkey agar and a green metallic sheen on Eosin Methylene Blue (EMB) agar.

    • EHEC Identification:

      • Identified through sorbitol non-fermentation on MacConkey agar (specific for O157:H7 strains).

  • Clinical Tests:

    • Urine cultures confirm UTIs, with >100,000 CFU/mL indicative of infection. Blood cultures are essential in sepsis diagnosis, while stool cultures and serotyping are necessary for gastrointestinal infections.

Treatment

  • UTIs:

    • First-line treatments include oral trimethoprim-sulfamethoxazole and nitrofurantoin for uncomplicated cystitis.

    • In cases of pyelonephritis, fluoroquinolones such as ciprofloxacin may be administered.

  • Sepsis:

    • Empirical therapy with broad-spectrum parenteral antibiotics (e.g., cefotaxime +/- gentamicin) is critical, with adjustments based on culture results.

  • Neonatal Meningitis:

    • Treatment involves high-dose ampicillin combined with cefotaxime to cover for both E. coli and listeria monocytogenes.

  • Diarrhea:

    • Supportive care is essential; antibiotics are contraindicated in EHEC infections due to the increased risk of HUS. Fluid replacement and rehydration are crucial.

Prevention

  • General Measures:

    • Individuals should avoid undercooked meats, unpasteurized dairy products, and contaminated water. Proper food handling and hygiene practices are crucial, especially during food preparation.

    • Catheter management is important in healthcare settings; they should be used judiciously and removed as soon as they are no longer necessary to prevent urinary tract infections.

    • Dietary measures, such as cranberry juice, may help inhibit E. coli by preventing the adhesion of bacteria to the urinary tract lining.

    • For travelers, prophylactic antibiotics or the use of bismuth subsalicylate (Pepto-Bismol) prior to travel can help prevent travel-associated diarrhea, alongside careful food choices to avoid exposure